[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[e-drug] Microbicides - seeking information

  • From: Kathy Attawell <attawell@msn.com>
  • Date: Tue, 1 Feb 2000 06:54:50 -0500 (EST)

E-drug: Microbicides - seeking information

Dear E-druggers,

I am conducting a study for the Population Council and International
Family Health, funded by the UK Department for International
Development, to find out what organisations are currently involved in
activities related to microbicides, what activities they are involved in,
and what organisations are interested in becoming more active in this
area. The study is part of a larger project, which is intended to
increase awareness among donors and policymakers of the potential
role of microbicides in HIV prevention, to develop strategies to
increase investment in research and testing and to speed up the
process of product development and availability. A brief project
summary is provided below as background information.

We would be very grateful if you could help us with this study by
responding to the following questions and returning to me at
attawell@msn.com :

1. Is your organisation currently involved in any activities related to
vaginal microbicides (for example, scientific or clinical research,
funding, advocacy and lobbying, policy research, behavioural
research, information and communication)? If yes, please summarise
these activities briefly.

2. Would your organisation be interested in being more actively
involved in policy development and action on microbicides? If yes,
please explain how you could help.

3. Are you aware of other organisations and individuals in your
country or elsewhere that are working in the field of microbicides
(research and scientific institutions, universities, private sector
companies and pharmaceutical firms, government or private donor
agencies, HIV/AIDS, reproductive health or women's groups,
advocacy organisations)? If yes, please could you provide as many
contact details as possible (name, address, telephone, e-mail) and
brief information about the type of work these organisations and
individuals are doing.

4. Would you be interested in receiving a copy of the study and case
statement (see project summary) when these are available?

Many thanks for your assistance.

Yours sincerely

Kathy Attawell
e-mail: attawell@msn.com

Rowena Taylor
International Family Health
United Kingdom
tel: 0044 171 247 9944
email: rtaylor@ifh.org.uk

[Reactions directly to authors of this message, please. Hilbrand Haak,
E-drug co-moderator]

Policy Dialogue and Action on Microbicides

With support from the UK Department for International Development,
the Population Council and International Family Health are
collaborating on a project intended to draw attention to the potential
role of microbicides in HIV/AIDS prevention. The project aims to
increase awareness among policymakers, donors and programme
managers and to generate more targeted research to shorten the time
to product availability. It hopes to build consensus on the feasibility,
strategy and relative priority of specific goals, such as: encouraging
greater interest among basic scientists in proposing and conducting
relevant research; attracting more private sector and public sector
investment; increasing public awareness through the media; and
raising the profile of microbicides at key international meetings.
Project activities will comprise: conducting a mapping exercise;
developing a case statement; and convening an interest group

Mapping exercise
The mapping exercise will provide information about organisations and
individuals working on issues related to microbicide development and
testing and their activities, what is not being done that might be, and
organisations and individuals that might be interested in playing a
more active role.

Case statement
An objective case statement will be developed, outlining what is
currently being done in the field, future prospects, and action needed
to move forward. Drawing on information from the mapping exercise,
interviews and meetings with key actors, and existing literature, the
case statement will cover: the need for female-controlled prevention
options; a review of the state of the art in research and testing and of
approaches currently being pursued; feasibility and timeframe for
product development; potential demand; cost and cost effectiveness;
the role of microbicides in relation to other approaches to HIV
prevention; and what is required to accelerate testing and product

Microbicides Interest Group Meeting
International Family Health and the Population Council will convene a
working meeting of organisations that already, or have the potential
to, play an active role in research and development, policy and
advocacy for microbidicide development. Participants will: review the
mapping exercise and the draft case statement; identify the objectives
of and strategies for policy education and awareness raising,
particularly in European and developing countries; and consider
whether there is interest in and an ongoing role for such a working

Dissemination and follow-up
The case statement, together with the Interest Group meeting
recommendations, will be shared with policymakers, programme
managers, NGOs, researchers and others, through targeted
international dissemination and through a special event to launch the
case statement at the XIII International Conference on AIDS in
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.